HSE-funded hospitals are getting large sums of money from big pharmaceutical companies which paid out €32.5m last year to a ...

A call has been made for “full transparency” about payments made by drug companies to healthcare professionals and healthcare ...

Professor Michael Barry, Clinical Director of the National Centre for Pharmacoeconomics, is calling for “full transparency” ...

The practice of drug company payments to healthcare professionals and health organisations in Ireland is widespread, a review ...

It has been a challenging couple of days in terms of education costs, with the squeeze coming on for those at both ends of the system. Parents of primary school pupils have been complaining about the ...

Pharmacoeconomics’ impact on Egypt’s oncology treatment evolution Facing constrained budgets and rising incidence of cancer, Egypt has established a specialist oncology committee and is taking ...

Jefferson Harte Nielson is a dynamic strategic leader who has showcased remarkable excellence in the ever-evolving ...

A new study has uncovered stark disparities in both lifespan and overall well-being among Australians, closely tied to their ...

Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in ...

Pharmacoeconomics of Empirical Antifungal Use in Febrile Neutropenic Hematological Malignancy and Hematopoietic Stem Cell Transplant Patients ...

Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor® Sy ...